Andrew D. Berti

1.5k total citations
29 papers, 989 citations indexed

About

Andrew D. Berti is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Andrew D. Berti has authored 29 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 11 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Andrew D. Berti's work include Antimicrobial Resistance in Staphylococcus (19 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Bacterial biofilms and quorum sensing (7 papers). Andrew D. Berti is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (19 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Bacterial biofilms and quorum sensing (7 papers). Andrew D. Berti collaborates with scholars based in United States, Australia and Canada. Andrew D. Berti's co-authors include Michael G. Thomas, Warren E. Rose, George Sakoulas, Emily E. Jackson, Matthew D. McMahon, Yolande A. Chan, Victor Nizet, Quin H. Christensen, Sanjay K. Shukla and Lucas Schulz and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Clinical Infectious Diseases.

In The Last Decade

Andrew D. Berti

27 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew D. Berti United States	15	469	382	364	186	154	29	989
Yuh Morimoto Japan	14	500 1.1×	504 1.3×	70 0.2×	196 1.1×	128 0.8×	30	934
Zhiwei Lin China	21	460 1.0×	319 0.8×	90 0.2×	175 0.9×	349 2.3×	41	965
Shang Wei Wu United States	16	705 1.5×	764 2.0×	96 0.3×	289 1.6×	250 1.6×	23	1.2k
Choon Kim United States	17	674 1.4×	488 1.3×	113 0.3×	129 0.7×	386 2.5×	40	1.1k
Bret M. Benton United States	18	590 1.3×	677 1.8×	338 0.9×	285 1.5×	262 1.7×	25	1.3k
Tomomi Hishinuma Japan	19	686 1.5×	710 1.9×	97 0.3×	300 1.6×	410 2.7×	47	1.2k
Nobuyuki Uehara Japan	13	412 0.9×	607 1.6×	65 0.2×	234 1.3×	113 0.7×	24	916
Anne Berscheid Germany	14	645 1.4×	235 0.6×	228 0.6×	37 0.2×	108 0.7×	23	1.1k
Gianpaolo Candiani Italy	10	314 0.7×	205 0.5×	198 0.5×	69 0.4×	72 0.5×	11	605
Maulik Thaker Canada	15	582 1.2×	116 0.3×	549 1.5×	52 0.3×	208 1.4×	15	1.0k

Countries citing papers authored by Andrew D. Berti

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Berti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Berti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Berti more than expected).

Fields of papers citing papers by Andrew D. Berti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Berti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Berti. The network helps show where Andrew D. Berti may publish in the future.

Co-authorship network of co-authors of Andrew D. Berti

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Berti. A scholar is included among the top collaborators of Andrew D. Berti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Berti. Andrew D. Berti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yi, Andrew D. Berti, Wessam Abdelhady, & Yan Q. Xiong. (2025). Prophage ϕSA169 Enhances Vancomycin Persistence in Methicillin-Resistant Staphylococcus aureus (MRSA). Antibiotics. 14(2). 191–191.

Giuliano, Christopher, Andrew D. Berti, Pramodini Kale-Pradhan, et al.. (2022). Clinical Outcomes of Zinc Supplementation Among COVID-19 Patients. Current Drug Safety. 17(4). 366–369. 3 indexed citations

Berti, Andrew D., et al.. (2022). Comparison of student pharmacists' performance on in-person vs. virtual OSCEs in a pre-APPE capstone course. Currents in Pharmacy Teaching and Learning. 14(9). 1116–1121. 7 indexed citations

Miller, Christopher R., Jonathan M. Monk, Richard Szubin, & Andrew D. Berti. (2021). Rapid resistance development to three antistaphylococcal therapies in antibiotic-tolerant staphylococcus aureus bacteremia. PLoS ONE. 16(10). e0258592–e0258592. 10 indexed citations

Baines, Sarah L., Benjamin P. Howden, Nagendra N. Mishra, et al.. (2020). Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin. Antimicrobial Agents and Chemotherapy. 64(9). 13 indexed citations

Miller, Christopher R., et al.. (2020). Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis. Antimicrobial Agents and Chemotherapy. 64(3). 7 indexed citations

Miller, Christopher R., Jonathan M. Monk, & Andrew D. Berti. (2020). 307. Rapid Resistance Development to Three Antistaphylococcal Therapies in Daptomycin-tolerant Staphylococcus aureus Bacteremia. Open Forum Infectious Diseases. 7(Supplement_1). S151–S151.

Berti, Andrew D., Hannah Turner, Ian R. Monk, et al.. (2018). Daptomycin selects for genetic and phenotypic adaptations leading to antibiotic tolerance in MRSA. Journal of Antimicrobial Chemotherapy. 73(8). 2030–2033. 24 indexed citations

Berti, Andrew D., William M. Curtis, Ruth Koepke, et al.. (2018). Meningococcal serogroup B outbreak response University of Wisconsin-Madison. Journal of American College Health. 67(3). 191–196. 7 indexed citations

10.

Berti, Andrew D., Sue McCrone, Mélanie Roch, et al.. (2017). Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 62(2). 22 indexed citations

11.

Rose, Warren E., Sanjay K. Shukla, Andrew D. Berti, et al.. (2017). Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia. Clinical Infectious Diseases. 64(10). 1406–1412. 39 indexed citations

12.

Berti, Andrew D., et al.. (2017). Evolution of Antibiotic Tolerance During Oxacillin, Daptomycin and Dalbavancin Therapy Results in Breakthrough Staphylococcus aureus Bacteremias. Open Forum Infectious Diseases. 4(suppl_1). S14–S14. 1 indexed citations

13.

Sakoulas, George, Warren E. Rose, Andrew D. Berti, et al.. (2016). Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 61(2). 18 indexed citations

14.

Berti, Andrew D., John‐Demian Sauer, Poochit Nonejuie, et al.. (2015). Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam–Daptomycin Synergy. Antimicrobial Agents and Chemotherapy. 60(1). 451–458. 45 indexed citations

15.

Berti, Andrew D., Paul R. Hutson, Lucas Schulz, Aaron P. Webb, & Warren E. Rose. (2015). Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion. American Journal of Health-System Pharmacy. 72(5). 390–395. 13 indexed citations

16.

Rose, Warren E., et al.. (2013). Relationship of In Vitro Synergy and Treatment Outcome with Daptomycin plus Rifampin in Patients with Invasive Methicillin-Resistant Staphylococcus aureus Infections. Antimicrobial Agents and Chemotherapy. 57(7). 3450–3452. 24 indexed citations

17.

Rose, Warren E., Lucas Schulz, David R. Andes, et al.. (2012). Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity. Antimicrobial Agents and Chemotherapy. 56(10). 5296–5302. 92 indexed citations

18.

Berti, Andrew D., et al.. (2012). Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics. Antimicrobial Agents and Chemotherapy. 56(10). 5046–5053. 52 indexed citations

19.

Jackson, Emily E., et al.. (2008). Nonribosomal Peptide Synthetases Involved in the Production of Medically Relevant Natural Products. Molecular Pharmaceutics. 5(2). 191–211. 232 indexed citations

20.

Rondon, Michelle R., et al.. (2007). Identification of the Biosynthetic Gene Cluster and an Additional Gene for Resistance to the Antituberculosis Drug Capreomycin. Applied and Environmental Microbiology. 73(13). 4162–4170. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact